no statement of use filed
on 12 Feb 2018
Last Applicant/ Owned by
3475 Edison Way, Suite S
Menlo Park
CA
940251821
Serial Number
87051378 filed on 26th May 2016
Registration Number
N/A
Correspondent Address
Mark G.P. Saifer, Ph.D.
Mountain View Pharmaceuticals, Inc.
Merry Sherman Ph.D., President
3475 Edison Way, Suite S
Menlo Park CA 94025-1821
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Contrasting agent for ultrasound diagnostic imaging; cells for medical or clinical use; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in gene therapy; pharmaceutical preparations for inhalation therapy; and vaccines PHARMACY PEG Chemical additives for use in the manufacture of pharmaceutical and cosmetic preparations and substances; diagnostic reageRead More
Chemical additives for use in the manufacture of pharmaceutical and cosmetic preparations and substances; diagnostic reagents for scientific or research use; cells for scientific, laboratory, or medical research; and chemical coatings used in the manufacture of medical devices to enhance biocompatibility; Diagnostic reagents for clinical or medical laboratory use
Contrasting agent for ultrasound diagnostic imaging; cells for medical or clinical use; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in gene therapy; pharmaceutical preparations for inhalation therapy; and vaccines
No 87051378
No Service/Collective Mark
No PHARMAPEG US
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
12th Feb 2018 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
12th Feb 2018 | ABANDONMENT - NO USE STATEMENT FILED |
13th Jun 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
09th Jun 2017 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
09th Jun 2017 | EXTENSION 1 GRANTED |
09th Jun 2017 | EXTENSION 1 FILED |
09th Jun 2017 | TEAS EXTENSION RECEIVED |
14th Jan 2017 | WITHDRAWAL OF ATTORNEY GRANTED |
14th Jan 2017 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
10th Jan 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |